Exelixis
EXEL
#1619
Rank
S$17.34 B
Marketcap
S$69.01
Share price
0.68%
Change (1 day)
24.17%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company